Bio-key International, Inc. (BKYI) Regains Nasdaq Compliance

BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that following the filing of its Form 10-Q for the quarter ended March 31, 2023, The Nasdaq Stock Market, LLC has informed the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission.

The Company’s Form 10-Q filing was delayed because the compilation and review of certain financial information could not be completed within the prescribed time period without unreasonable effort and expense.

About BIO-key International, Inc. (www.BIO-key.com)BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy to deploy, convenient and secure access to devices, information, applications, and high-value transactions. BIO-key’s patented software and hardware solutions, with industry-leading Identity-Bound Biometric (IBB) capabilities, enable large-scale Identity-as-a-Service (IDaaS) solutions, as well as customized on premises solutions.

Investor Contacts:William Jones, David CollinsCatalyst IR[email protected]212-924-9800

Source: BIO-key International, Inc.

You May Also Be Interested In

• Arrowhead's plozasiran cuts pancreatitis events 78% in Phase 3 data
• SuperX wins 128-unit B300 server order from Australian firm Ezisight
• Niutech signs deal with unnamed energy firm for plastic-to-SAF line